The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer

被引:30
作者
Kwa, HB
Michalides, RJAM
Dijkman, JH
Mooi, WJ
机构
[1] UNIV LEIDEN HOSP,DEPT PULMONOL,2300 RC LEIDEN,NETHERLANDS
[2] NETHERLANDS CANC INST,DIV TUMOR BIOL H5,1066 CX AMSTERDAM,NETHERLANDS
关键词
non-small cell lung carcinoma; prognostic factors; NCAM P53 protein; cyclin D1; immunohistochemistry;
D O I
10.1016/0169-5002(96)00547-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of the neural cell adhesion molecule, NCAM, in frozen sections has been associated with decreased postoperative survival in non-small cell lung carcinoma. Of the various isoforms of NCAM described, the highly sialylated isoform plays a role in the migration of embryonal cells from the neural crest and is expressed by highly malignant tumours such as small cell lung carcinomas. We investigated the clinical significance of expression of this NCAM isoform as a prognostic factor in a series of 96 non-small cell lung carcinomas resected with curative intent. We also evaluated the effect of microwave pretreatment of formalin-fixed, paraffin-embedded sections on the NCAM immunostaining and related the outcome to the postoperative clinical course of disease. In addition, in an attempt to extend our search for possible molecular markers of unfavourable prognosis in lung cancer, we evaluated increased immunostaining for p53 and cyclin D1 in the same series. We did nor find a significant relation between expression of NCAM or its highly sialylated isoform and the length of postoperative survival, The numbers of positive cases (9 and 14, respectively) were relatively low. Increased p53 and cyclin D1 immunostaining (50 and 55 of the 96 tumours) failed io show a significant relation with postoperative survival. In our material, tumour stage was the only significant prognostic factor.
引用
收藏
页码:207 / 217
页数:11
相关论文
共 42 条
  • [1] NCAM POLYSIALIC ACID CAN REGULATE BOTH CELL CELL AND CELL SUBSTRATE INTERACTIONS
    ACHESON, A
    SUNSHINE, JL
    RUTISHAUSER, U
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 114 (01) : 143 - 153
  • [2] NCAM - A SURFACE MARKER FOR HUMAN SMALL-CELL LUNG-CANCER CELLS
    ALETSEEUFRECHT, MC
    LANGLEY, K
    ROTSCH, M
    HAVEMANN, K
    GRATZL, M
    [J]. FEBS LETTERS, 1990, 267 (02) : 295 - 300
  • [3] CLINICAL CHARACTERIZATION OF NON-SMALL-CELL LUNG-CANCER TUMORS SHOWING NEURO-ENDOCRINE DIFFERENTIATION FEATURES
    BERENDSEN, HH
    DELEIJ, L
    POPPEMA, S
    POSTMUS, PE
    BOES, A
    SLUITER, HJ
    THE, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1614 - 1620
  • [4] BEVERLY PCL, 1988, LUNG CANCER, V4, P15
  • [5] BODNER SM, 1992, ONCOGENE, V7, P743
  • [6] PROGNOSTIC FACTORS IN LUNG-CANCER - TABLES AND COMMENTS
    BUCCHERI, G
    FERRIGNO, D
    [J]. EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (07) : 1350 - 1364
  • [7] BUCKLEY MF, 1993, ONCOGENE, V8, P2127
  • [8] P53 IMMUNOSTAINING POSITIVITY IS ASSOCIATED WITH REDUCED SURVIVAL AND IS IMPERFECTLY CORRELATED WITH GENE-MUTATIONS IN RESECTED NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT OF LCSG-871
    CARBONE, DP
    MITSUDOMI, T
    CHIBA, I
    PIANTADOSI, S
    RUSCH, V
    NOWAK, JA
    MCINTIRE, D
    SLAMON, D
    GAZDAR, A
    MINNA, J
    [J]. CHEST, 1994, 106 (06) : S377 - S381
  • [9] EBINA M, 1994, CANCER RES, V54, P2496
  • [10] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825